Viewray News

Stifel Nicolaus Keeps Their Hold Rating on Viewray (VRAY)

TipRanksJun 6, 2023 22:17 ET

Analysts Conflicted on These Healthcare Names: Pliant Therapeutics (PLRX), Krystal Biotech (KRYS) and Viewray (VRAY)

TipRanksMay 29, 2023 22:10 ET

Viewray (VRAY) Receives a Hold From Stifel Nicolaus

TipRanksMay 24, 2023 22:08 ET

B. Riley Securities Downgrades ViewRay to Neutral, Lowers Price Target to $1

BenzingaMay 11, 2023 08:46 ET

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $1

BenzingaMay 11, 2023 08:33 ET

BTIG Remains a Hold on Viewray (VRAY)

TipRanksMay 10, 2023 21:45 ET

Piper Sandler Maintains Overweight on ViewRay, Lowers Price Target to $2

BenzingaApr 24, 2023 10:07 ET

Jefferies Downgrades ViewRay to Hold, Lowers Price Target to $1.25

BenzingaApr 17, 2023 05:41 ET

Jefferies Downgrades Viewray (VRAY) to a Hold

TipRanksApr 17, 2023 05:02 ET

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Tonix Pharma (TNXP) and Viewray (VRAY)

TipRanksApr 14, 2023 08:32 ET

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $2

BenzingaApr 14, 2023 08:11 ET

B. Riley Lowers ViewRay's Price Target to $4 From $8 After Softer-Than-Expected Q1 Revenue, Keeps Buy Rating

MT NewswiresApr 14, 2023 07:39 ET

Stifel Downgrades ViewRay to Hold, Lowers Price Target to $1.75

BenzingaApr 14, 2023 05:31 ET

Stifel Nicolaus Downgrades Viewray (VRAY) to a Hold

TipRanksApr 14, 2023 04:16 ET

B.Riley Financial Keeps Their Buy Rating on Viewray (VRAY)

TipRanksApr 13, 2023 21:36 ET

BTIG Gives a Buy Rating to Viewray (VRAY)

TipRanksApr 13, 2023 09:51 ET

Oppenheimer Keeps Their Buy Rating on Viewray (VRAY)

TipRanksFeb 28, 2023 11:31 ET

Oppenheimer Reiterates Outperform on ViewRay, Maintains $8 Price Target

BenzingaFeb 28, 2023 07:57 ET

Morgan Stanley Sticks to Its Hold Rating for Viewray (VRAY)

TipRanksFeb 28, 2023 07:21 ET

BTIG Sticks to Its Buy Rating for Viewray (VRAY)

TipRanksFeb 28, 2023 00:15 ET